Atossa Therapeutics Inc Revenue 2011–2015
Atossa Therapeutics Inc annual/quarterly revenue history and growth rate from 2011 to 2016. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Atossa Therapeutics Inc revenue for the quarter ending September 30, 2016 was 0.
- Atossa Therapeutics Inc revenue for the twelve months ending September 30, 2016 was 0, a 100.00% decrease year-over-year.
- Atossa Therapeutics Inc annual revenue for 2015 was 1758, a 95.62% decrease from 2014.
- Atossa Therapeutics Inc annual revenue for 2014 was 40138, a 93.65% decrease from 2013.
- Atossa Therapeutics Inc annual revenue for 2013 was 632558, a 31.28% increase from 2012.
- Atossa Therapeutics Inc annual revenue for 2012 was 481842.
Atossa Therapeutics Inc (ATOS) — Frequently Asked Questions
Atossa Therapeutics Inc (ATOS) is a publicly traded US company. It has a market capitalization of $83M. In fiscal 2015 it reported revenue of $1,758 and net income of -$16M. Explore ATOS's stock price, financial statements, earnings history, margins and key ratios below.
What is Atossa Therapeutics Inc's market cap?
Atossa Therapeutics Inc (ATOS) has a market capitalization of $83M.
What is the ATOS stock price?
ATOS trades at $2.55 (-42.05% on the day).
How much revenue does Atossa Therapeutics Inc make?
Atossa Therapeutics Inc reported revenue of $1,758 in fiscal 2015.
Is ATOS profitable?
In fiscal 2015, Atossa Therapeutics Inc reported net income of -$16M.